| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |